Elongin A2 inhibitors are a class of chemical compounds designed to selectively inhibit the function of the protein Elongin A2. Elongin A2 is a subunit of the Elongin complex, which plays a crucial role in regulating the transcription elongation process by RNA polymerase II. This complex is involved in enhancing the elongation phase of transcription by helping to overcome blocks caused by nucleosomes and other obstacles along the DNA. Specifically, Elongin A2 contributes to the modulation of transcriptional activity by associating with other regulatory proteins, thereby influencing gene expression and cellular function. Inhibitors of Elongin A2 are small molecules that target this protein's function and disrupt its ability to facilitate the transcription elongation process. These inhibitors have been identified through biochemical and high-throughput screening assays designed to find compounds that effectively bind to Elongin A2 and impede its function within the Elongin complex.
Structurally, Elongin A2 inhibitors exhibit diverse chemical frameworks, often featuring functional groups that allow for interaction with the binding sites on Elongin A2, such as aromatic rings, heterocycles, and amide linkages. These structural elements are critical for the specificity and potency of the inhibitors against Elongin A2. By binding to Elongin A2, these compounds can modulate the activity of the Elongin complex, providing a mechanism to study the transcriptional regulation of specific genes. Given the complex's role in controlling transcriptional elongation, Elongin A2 inhibitors serve as important molecular tools for understanding how elongation is regulated and how it affects gene expression at a cellular level. Studies of these inhibitors have enhanced our knowledge of transcriptional dynamics, protein-protein interactions, and the overall architecture of transcription regulation, providing significant insights into molecular biology and biochemistry.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Could suppress the transcriptional elongation of the Elongin A2 gene by directly inhibiting the enzymatic activity of RNA polymerase II, leading to decreased levels of Elongin A2 mRNA and protein. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Might intercalate into DNA sequences, particularly at the transcription initiation site of Elongin A2, obstructing the advancement of RNA polymerase II and leading to a decrease in Elongin A2 transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Could specifically bind to and inhibit RNA polymerase II, thereby decreasing the synthesis of Elongin A2 mRNA and subsequently reducing its protein levels. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Might selectively inhibit the phosphorylation of the C-terminal domain of RNA polymerase II, resulting in the reduction of transcription elongation efficiency for the Elongin A2 gene. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
May block DNA methyltransferases, potentially leading to demethylation of the Elongin A2 promoter region and a subsequent decrease in gene expression due to changes in chromatin accessibility. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Could bind to G-C rich regions within the promoter of the Elongin A2 gene, hindering the binding of transcription factors necessary for the initiation of Elongin A2 transcription, thus decreasing its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Might inhibit histone deacetylase activity, leading to hyperacetylation of histones near the Elongin A2 gene, which could inadvertently lead to the downregulation of its expression due to complex effects on chromatin structure and gene accessibility. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May be incorporated into the Elongin A2 gene during DNA replication, leading to the inhibition of DNA methyltransferase and a subsequent reduction in methylation levels, which could decrease Elongin A2 expression. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
Could inhibit the G9a histone methyltransferase, altering histone methylation marks associated with the Elongin A2 gene and leading to a decrease in its expression. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
Might inhibit SUV39H1, a histone methyltransferase, thereby altering the trimethylation of histone H3 at lysine 9 near the Elongin A2 gene, potentially resulting in decreased expression. | ||||||